Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-04FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc. The document does not specify the cha…
-
FDA approval · 2009-11-04FDA Approved: LAMOTRIGINE — Original Application (Aurobindo Pharma Limited)
FDA approved a new generic lamotrigine product from Aurobindo Pharma Limited under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
A completed epidemiological study sponsored by AstraZeneca evaluated adherence to treatment in patients with bipolar disorder.
-
CLINICAL_TRIALS research · 2009-10-23Clinical Trial Update: Juvenile Bipolar Disorder Outpatient Program [Phase 4]
Phase 4 juvenile bipolar disorder outpatient trial update; current status is unknown for the study involving bipolar disorder and attention-…
-
FDA approval · 2009-09-25FDA Approved: LITHIUM CARBONATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' lithium carbonate as a generic, marking the Original Application under ANDA090702 for market authorizat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms. [Phase 3]
A Phase 3 trial evaluating the Bipolar Disease Program (BDP) Intervention for long-term manic and depressive symptoms in bipolar disorder ha…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Medication Adherence in Older Adults With Serious Mental Illness [NA]
The entry reports completion of a clinical trial evaluating medication adherence in older adults with serious mental illness, including schi…
-
FDA approval · 2009-09-22FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approves a supplemental application for the Lamotrigine Kit from OWP Pharmaceuticals, Inc. under ANDA078947, confirming the continued av…
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for lamotrigine filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for Lamotrigine by Dr. Reddy's Laboratories Limited, updating an existing Lamotrigine product. T…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment [Phase 4]
This clinical trial update reports the termination of a Phase 4 placebo-controlled study evaluating escitalopram for acute and maintenance t…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder [NA]
This completed clinical trial assessed whether a lifestyle intervention affected body mass index in people with bipolar disorder. The study …
-
FDA approval · 2009-09-04FDA Approved: RISPERIDONE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for risperidone, a generic antipsychotic, authorizing its manufacturing and mar…
-
FDA approval · 2009-08-31FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company. The action concerns the ZYPREXA Z…
-
FDA approval · 2009-08-24FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for risperidone by Amici Pharma, Inc., signaling a labeling update or additional indication for the …
-
CLINICAL_TRIALS research · 2009-08-19Clinical Trial Update: Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox
A completed non-interventional study in bipolar disorder and schizophrenia assessing Zeldox (ziprasidone) by Pfizer/Mylan Viatris; results p…
-
CLINICAL_TRIALS research · 2009-08-17Clinical Trial Update: Far Infrared Radiation Treatment for Bipolar Condition [Phase 1]
This entry reports a Phase 1 clinical trial evaluating far infrared radiation treatment for bipolar disorder. The trial is sponsored by GAAD…
-
FDA approval · 2009-08-13FDA Approved: SAPHRIS — Original Application (Allergan, Inc.)
The FDA approved SAPHRIS (asenapine maleate) from Allergan in an original application for the treatment of schizophrenia and for the acute t…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
A completed clinical trial evaluated prolactin changes in patients with antipsychotic-induced hyperprolactinemia after switching to quetiapi…
-
FDA approval · 2009-08-04FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
FDA has approved a supplemental application for divalproex sodium from BluePoint Laboratories.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
Observational study evaluating the effectiveness of olanzapine-coated and orodispersible tablets in outpatients with schizophrenia or bipola…
-
FDA approval · 2009-07-19FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) from Janssen Pharmaceuticals. The notice lists the submission stat…
-
FDA approval · 2009-07-19FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder [Phase 3]
Phase 3 trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder has complete…